Clinical trial
An Overall Solution for Full-course Oral Anti-tumor Drug Services Based on Mobile Medicine
NCT05049811 is registered in ClinicalTrials.gov with Fujian Cancer Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Overall Solution for Full-course Oral Anti-tumor Drug Services Based on Mobile Medicine
- Lead sponsor
- Fujian Cancer Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 30, 2021
- Completion date
- June 30, 2022
- Enrollment
- 200 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.